Skip to main content
SpringerLink
Log in

Spectrum of monoclonal gammapathies in Andhra Pradesh

  • Cancer
  • Published:
Indian Journal of Clinical Biochemistry Aims and scope Submit manuscript

Abstract

In the present study, monoclonal gammapathy was identified in a total of 245 patients of plasma cell dyscrasias during period of 1987 to 2000. The monoclonal band was identified in serum by agar gel electrophoresis in all the cases and in urine in a few cases. Characterization of paraprotein (monoclonal immunoglobulin class and light chain type) was carried out by employing immunoelectrophoresis and/or immunofixation electrophoresis using heavy chain specific gamma, alpha, mu, delta and epsilon and light chain specific kappa (K), lambda (λ) antisera. Serum immunoglobulins Ig G, Ig A, and Ig M were estimated by immunoturbidometry. Serum urea, creatinine, uric acid, alkaline phosphatase, total proteins, albumin, calcium and phosphorus were estimated by using routine biochemical methods. Among the 245 cases, 73.1% monoclonal gammapathies were of secretory type and 7.3% were non-secretory. Monoclonal gammapathies were associated with 80.4% of multiple myeloma, 8.9% of solitary plasmacytoma, 4.1% of extra-medullary plasmacytoma, 3.3% of lymphoma and 2.9% of plasma cell leukemia. Classification of secretory monoclonal immunoglobulin revealed monoclonal immunoglobulin Ig G in 74%, Ig A 15% and Ig M in 2.9% cases.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Aguzzi, F., Bergaml, M.R., Gasparro, C., Bellotti, V. and Merlini, G. (1992) Occurence of monoclonal components in general practice: Clinical implications. Eur. J. Haematol. 48, 192–195.

    Article  PubMed  CAS  Google Scholar 

  2. Salmon, S.E. and Cassady, J.R. (1993) Plasma cell neoplasms in cancer: Principles and practice of oncology. Eds. Devita, V.T. Jr., Hellman, S. and Rosenberg, S.A. J.B. Lippincott company, Philadelphia, USA p. 1984–2025.

    Google Scholar 

  3. Osterland, C.K. (1989) Monoclonal gammapathies-their identification and biological significance. Clinica Chim. Acta 180, 1–22.

    Article  CAS  Google Scholar 

  4. Osserman, E.F. and Takatsuki, K (1963) Plasma cell myeloma: Gammaglobulin synthesis and structure. and Medicine. 42, 357–384.

    CAS  Google Scholar 

  5. Kyle, R.A. (1975) Multiple myeloma review of 869 cases. Mayo Clin. Proc. 50, 29–40.

    PubMed  CAS  Google Scholar 

  6. Merlini, G.E., Waldenstrom, J. and Jayakar, S.D. (1980) A new improved clinical staging system for multiple myeloma based on analysis of 123 treated patients. Blood. 55, 1011–1019.

    PubMed  CAS  Google Scholar 

  7. Osserman, E.F., Merlini, G. and Butler, P.V. (1989) Multiple Myeloma and related plasma cell dyscrasias. J. Amer. Med. Assoc. 4, 354–361.

    Google Scholar 

  8. Blattner, W.A. (1980) Epidemiology of multiple myeloma and related plasma cell disordrs: An analytic review, In: Preogress in Myeloma. Ed. Potter, M. Elsevier Science publishers, Amsterdam. p. 1–65.

    Google Scholar 

  9. Waldentstrom, J. (1965) Macroglobulinemia. Adv. Metab. Dis. 2, 115.

    Google Scholar 

  10. Kyle, R.A. (1995) Waldenstrom's macroglobulinemia. In: Myeloma-Biology and Management Eds. Malpas, J.S., Bergsagel, D.E., Kyle, R.A. Oxford University Press, Oxford, p. 543–564.

    Google Scholar 

  11. Bence Jones, H. (1847) Papers on chemical pathology; prefaced by the galstonian lecture read at the Royal college of physicians, Lecture-3, Lancet 2, 88–92.

    Article  Google Scholar 

  12. Solomon, A., Waldmann, T.A. and Fahey, J.L. (1964) Metabolism of Bence Jones Proteins. J. Clin. Invest. 43, 103–117.

    Article  PubMed  CAS  Google Scholar 

  13. Knowling, M.A., Harwood, A. and Bergsagel, D.E. (1983) A comparison of extramedullary plasmacytomas with solitary and multiple plasma cell tumors of bone. J. Clin. Oncol. 1, 255–262.

    PubMed  CAS  Google Scholar 

  14. Franklin, E. C. (1984) The heavy chain diseases. Harvey Lecture. 78, 1–22.

    Google Scholar 

  15. Kyle, R.A., Greipp, P.R. and Banks, P.M. (1981) The diverse picture of gamma heavy-chain disease: Report of seven cases and review of literature. Mayo Clin. Proc. 56, 439.

    PubMed  CAS  Google Scholar 

  16. Fermand, J.P., Brovet, J.C., Danon, F. and Seligmann, M (1989) Gamma heavy chain disease, heterogeneity of the clinico-pathologic features. Report of 16 cases and review of the literature. Medicine (Baltimore). 68, 321–335.

    CAS  Google Scholar 

  17. Finkel, P.N., Kronenberg, K. and Pesce, A.J. (1973) Adult Fanconi syndrome, amyloidosis and marked kappa light chain proteinuria. Nephrrn. 10, 1–24.

    CAS  Google Scholar 

  18. Subbarao, K. and Jacobson, H.G. (1986) Amyloidosis & Plasma cell dyscrasias of the musculo skeletal system. Seminars in Roentgenology 21, 139–149.

    Article  PubMed  CAS  Google Scholar 

  19. Siegelman, S.S. (1981) Plasma cell dyscrasias. In syllabus, Metabolic and Endocrine disorders affecting the skeleton: The radiological Society of North America. Ed. Jacobson, H.G. 609, C2-609 C-8.

  20. Gupta, R.M., Varma, B.P., Gupta, I.M. and Gupta, Y.N. (1974) Myeloma-A correlated clinico-pathologic and immunologic study. Ind. J. Orthopaed. 8(2), 142–148.

    Google Scholar 

  21. Sehgal, S., Datta, Usha., Gulati, D.R., Grover, A. and Gupta, B.D. (1980) Spectrum of Lymphoid malignancies with particular reference of plasma cell dyscrasias in Chandigarh, India. In: Pathogenesis of Leukemias and Lymphomas: Environmental influences, Eds. Magrath, I.T., O'Conor, G.T. and Ramot, B. Raven press, New York, p. 47–59.

    Google Scholar 

  22. Innes, J. and Newell, J. (1961) Myelomatosis. Lancet, 1, 239.

    Article  PubMed  CAS  Google Scholar 

  23. Martin, N.H. (1961) The incidence of Myelomatosis. Lancet, 1, 237.

    Article  PubMed  CAS  Google Scholar 

  24. Yacoub, G.S. and Dubaybo, B.A. (1999) Plasmacytoma and upper airway obstruction. Amer. J. Otolaryngol 20(4), 257–259.

    Article  CAS  Google Scholar 

  25. Rai, B., Chopra, B.K. and Dang, H.S. (1971) Multiple Myeloma: Clinical and laboratory findings in 22 cases. J. Assoc. Physicians of India. 19, 563–566.

    CAS  Google Scholar 

  26. Bergsagel, D.E. (1982) Plasma cell neoplasms and acute leukemia. In: Clinics in Hematology Eds. Hoffbrand, A.V., Lasch, H.G., Nathan, D.G. Salmon, S.E. (guest ed.): Clin. Haematol, W.B. Saunders, Eastboume. 11, 221–234.

    Google Scholar 

  27. Bergsagel, D.E., Bailey, A.J. and Langley, G.R. (1979) The Chemotherapy of plasma cell myeloma and the incidence of acute leukemia. New Engl. J. Med. 301, 743.

    Article  PubMed  CAS  Google Scholar 

  28. Ko, H.S. and Pruzanski, W. (1976) M Components associated with lymphoma: a review of 62 cases. Amer. J. Med. Sci. 272, 175–183.

    Article  PubMed  CAS  Google Scholar 

  29. Jacobson, D.R. and Zolla-Pazner, S. (1986) Immunosupression and infection in multiple myeloma. Semin. Oncol. 13, 282–290.

    PubMed  CAS  Google Scholar 

  30. Nemni, R., Gerosa, E., Piccolo, G. and Merlini, G. (1994) Neuropathies associated with monoclonal gammapathies. Hematologica 79, 557–566.

    CAS  Google Scholar 

  31. Kapadia, S.B. (1980) Multiple myeloma, A clinicopathological study of 62 consecutively autopsied cases. Medicine (Baltimore), 59, 380.

    Article  CAS  Google Scholar 

  32. Martinez Maldonado, M., Gium, J., Suki, W.N., Eknoyan, G (1971) Renal complications in multiple myeloma, pathophysiology and some aspects of clinical management. J. Chronic. Dis. 24, 221–257

    Article  PubMed  CAS  Google Scholar 

  33. Thorner, P.S., Bedard, Y.C., Fernandes, B.J. (1983) Lambda light chain nephropathy with Fanconi's syndrome. Arch. Path. & Lab. Med. 107(12), 654–657.

    CAS  Google Scholar 

  34. Soloman, A., Weiss, D.T. and Kattine, A.A. (1991) Nephrotoxic potential of Bence Jones proteins. New Engl. J. Med., 324, 1845–1851.

    Article  Google Scholar 

  35. Maldonado, J.E., Velosa, J.A. and Kyle, R.A. (1975) Fanconi syndrome in adults: A manifestation of a latent form of myeloma. Amer. J. Med. 58, 354–364.

    Article  PubMed  CAS  Google Scholar 

  36. Payne, R., Little, A. and Williams, R., Brit. Med. J. (1973) Interpretation of serum calcium in patients with abnormal serum proteins. Brit. Med. J., 4, 643.

    Article  PubMed  CAS  Google Scholar 

  37. Kyle, R.A. (1999) Maintenance therapy and supportive care for patients with multiple myeloma. Semin. Oncol. 26, (5 suppl 13), 35–42.

    PubMed  CAS  Google Scholar 

  38. McCloskey, E.V., Galloway, J., Morgan, M.A. and Kanis, J.A. (1989) Pseudohyperphosphataemia multiple myeloma. Brit. Med. J. 299, 1381–1382.

    PubMed  CAS  Google Scholar 

  39. McCloskey, E.V., Yates, A.J.P., Gray, R.E.S., Hamdy, N.A.T., Galloway, J. and Kanis, J.A. (1988) Diphosphonates and phosphate homeostasis in man. Clin. Sci. 74, 607–612.

    PubMed  CAS  Google Scholar 

  40. Hart, J.S., Lawrence, M.C., Ritzmann, S.E. and Levin, W.C. (1965) II Hyper and hypoproteinemias 1. Hyperproteinemia. Correlation of elevated total serum protein values and their responsible globulin fractions with various polyclonal and monoclonal gammapathies. A study of 173 sera. Tex. Rep. Biol. Med. 23, 445–457.

    PubMed  CAS  Google Scholar 

  41. Cox, E.B. (1980) Prognosis in myeloma: key role of uric acid in azotemia. Proc. AACR-ASCO 21, 483.

    Google Scholar 

  42. Durie, B.G.M., Salmon, S.E. and Moon, T.E. (1980) Pretreatment tumor mass, cell kinetics and prognosis in multiple myeloma. Blood 55, 364–372.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Biochemistry, Nizam's Institute of Medical Sciences, Punjagutta, 500 082, Hyderabad, Andhra Pradesh, India

    T. Malati, B. Yadagiri & D. Murali Mohan Krishna

  2. Department of General Medicine, Nizam's Institute of Medical Sciences, Punjagutta, 500 082, Hyderabad, Andhra Pradesh, India

    V. Shantaram

  3. Department of Medical Oncology, Nizam's Institute of Medical Sciences, Punjagutta, 500 082, Hyderabad, Andhra Pradesh, India

    D. Raghunadharao

  4. Department of Radiology, Nizam's Institute of Medical Sciences, Punjagutta, 500 082, Hyderabad, Andhra Pradesh, India

    K. Subbarao

Authors
  1. T. Malati
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. B. Yadagiri
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. D. Murali Mohan Krishna
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. V. Shantaram
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. D. Raghunadharao
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. K. Subbarao
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Malati, T., Yadagiri, B., Krishna, D.M.M. et al. Spectrum of monoclonal gammapathies in Andhra Pradesh. Indian J Clin Biochem 16, 52–59 (2001). https://doi.org/10.1007/BF02867568

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02867568

Key Words

Search

Navigation